Borecky D J, Stephenson J J, Keeling J H, Vukelja S J
Department of Medicine, Brooke Army Medical Center, Fort Sam Houston, Texas 78234, USA.
Cutis. 1997 Apr;59(4):203-4.
A case of acute myelocytic leukemia of the FAB-M2 subtype in a patient who experienced pigmentary nail changes in conjunction with idarubicin therapy is presented. Although doxorubicin and daunorubicin have been reported to cause nail pigmentation changes, this is the first case report to describe these changes with idarubicin.
本文报告了1例FAB-M2亚型急性髓细胞白血病患者,在接受伊达比星治疗时出现指甲色素沉着改变。尽管已有报道称阿霉素和柔红霉素可引起指甲色素沉着改变,但这是首例描述伊达比星引起此类改变的病例报告。